Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $27.8 million.

  • Neurocrine Biosciences' Other Working Capital Changes fell 245.61% to $27.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $44.4 million, marking a year-over-year decrease of 1777.78%. This contributed to the annual value of $44.4 million for FY2025, which is 1777.78% down from last year.
  • Latest data reveals that Neurocrine Biosciences reported Other Working Capital Changes of $27.8 million as of Q4 2025, which was down 245.61% from $42.1 million recorded in Q3 2025.
  • In the past 5 years, Neurocrine Biosciences' Other Working Capital Changes registered a high of $50.9 million during Q3 2023, and its lowest value of -$71.4 million during Q2 2023.
  • Moreover, its 4-year median value for Other Working Capital Changes was $18.8 million (2024), whereas its average is $10.0 million.
  • The largest annual percentage gain for Neurocrine Biosciences' Other Working Capital Changes in the last 5 years was 13235.29% (2025), contrasted with its biggest fall of 111212.12% (2025).
  • Quarter analysis of 4 years shows Neurocrine Biosciences' Other Working Capital Changes stood at $2.6 million in 2021, then soared by 850.0% to $24.7 million in 2023, then rose by 15.38% to $28.5 million in 2024, then fell by 2.46% to $27.8 million in 2025.
  • Its Other Working Capital Changes was $27.8 million in Q4 2025, compared to $42.1 million in Q3 2025 and -$33.4 million in Q2 2025.